Clinical application of butylphthalide sequential therapy on PTX-3, S100B, IL-6 in acute cerebral infarction

PTX-3, S100B, IL-6 in acute cerebral infarction

  • Pin Meng Department of Neurology, The First People’s Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University
  • Jianyu Zhang Department of Neurology, The First People’s Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu 222000, China.
  • Jiaojiao Li Department of Neurology, The First People’s Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu 222000, China.
  • Niu Ji Department of Neurology, The First People’s Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu 222000, China.
  • Xinyu Zhou Department of Neurology, The First People’s Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu 222000, China.
  • Bingchao Xu Department of Neurology, The First People’s Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, Jiangsu 222000, China.
DOI: https://doi.org/10.5937/jomb0-57276
Keywords: PTX-3, S100B, IL-6 ,acute cerebral infarction, cognitive dysfunction, butylphthalide sequential therapy, neurological function.

Abstract


Background: Acute cerebral infarction (ACI) belongs to a frequent type of stroke disease in clinical practice. Cognitive dysfunction is a common complication of ACI, which severely influences the quality of life of patients.

Objective: To probe the influence of butylphthalide sequential therapy in acute cerebral infarction (ACI) and serum on PTX-3, S100B, IL-6.

Methods: A total of 120 patients with ACI combined with cognitive dysfunction diagnosed and received treatments in our hospital from March 2023 to March 2024 were separated into control group (CG) as well as observation group (OG) in random. The clinical effective rate, MMSE scores, NIHSS scores, Barthel index scores, levels of inflammatory factors along with incidence of complications in both groups were compared.

Results: Compared to the CG, the total effective rate of the OG was higher (χ2=4.90, P<0.05). MMSE scores and Barthel index scores were elevated in both groups 2 weeks and 2 months after treatment, and those in the OG were higher relative to the CG (P<0.05). NIHSS scores and hs-CRP, as well as PTX-3 levels were declined in both groups 2 weeks and 2 months after treatment, and those in the OG were lessened compared to the CG (P<0.05). The occurrence of complications in the OG was lessened relative to the CG (P<0.05). Serum analysis showed lower hs-CRP, PTX-3, and IL-6 levels in the OG (P<0.05), suggesting reduced inflammation with butylphthalide therapy. While S100B levels showed a non-significant decline, albumin levels remained unchanged, indicating no major impact on neuronal injury or nutritional recovery (P>0.05).

Conclusion: Butylphthalide sequential therapy can promote the neurological function as well as living ability of patients with ACI combined with cognitive dysfunction, with high safety, which is valuable for clinical promotion.

References

References
1. Edwards, M.D. and T.A.T. Hughes, Managing blood pressure in acute cerebral infarction. J Neurol, 2021. 268(6): p. 2294-2296.
2. Yang, B.B., et al., Astaxanthin attenuates acute cerebral infarction via Nrf-2/HO-1 pathway in rats. Curr Res Transl Med, 2021. 69(2): p. 103271.
3. Tsai, C.F., et al., Cerebral infarction in acute anemia. J Neurol, 2010. 257(12): p. 2044-51.
4. Feng, L., et al., Reduced thiamine is a predictor for cognitive impairment of cerebral infarction. Brain Behav, 2020. 10(9): p. e01709.
5. Zeng, Q., et al., Correlations of serum cystatin C level and gene polymorphism with vascular cognitive impairment after acute cerebral infarction. Neurol Sci, 2019. 40(5): p. 1049-1054.
6. Yang, W., et al., Exogenous insulin-like growth factor 1 attenuates acute ischemic stroke-induced spatial memory impairment via modulating inflammatory response and tau phosphorylation. Neuropeptides, 2020. 83: p. 102082.
7. Chen, L., et al., Impact of cerebral microbleeds on cognitive functions and its risk factors in acute cerebral infarction patients. Neurol Res, 2023. 45(6): p. 564-571.
8. Kunes, P., et al., Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm, 2012. 2012: p. 920517.
9. Zhao, Q.S., et al., Clinical treatment efficiency of mechanical thrombectomy combined with rhPro-UK thrombolysis for acute moderate/severe cerebral infarction. Eur Rev Med Pharmacol Sci, 2018. 22(17): p. 5740-5746.
10. Wang, Z. and J. Che, Effectiveness of alteplase intravenous thrombolysis combined with butylphthalide in patients with acute severe cerebral infarction. Folia Neuropathol, 2022. 60(4): p. 421-426.
11. Zhu, C., Effect and clinical evaluation of butylphthalide combined with Ureklin on ischemic low perfusion area in patients with acute cerebral infarction. Minerva Med, 2022.
12. Li, J., et al., Effects of L-3-n-butylphthalide on cognitive dysfunction and NR2B expression in hippocampus of streptozotocin (STZ)-induced diabetic rats. Cell Biochem Biophys, 2015. 71(1): p. 315-22.
13. Jia, X., et al., A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC Psychiatry, 2021. 21(1): p. 485.
14. Alemseged, F., et al., Posterior National Institutes of Health Stroke Scale Improves Prognostic Accuracy in Posterior Circulation Stroke. Stroke, 2022. 53(4): p. 1247-1255.
15. Liu, F., et al., Relationship of Barthel Index and its Short Form with the Modified Rankin Scale in acute stroke patients. J Stroke Cerebrovasc Dis, 2020. 29(9): p. 105033.
16. Yan, W., et al., Decreased neuronal synaptosome associated protein 29 contributes to poststroke cognitive impairment by disrupting presynaptic maintenance. Theranostics, 2021. 11(10): p. 4616-4636.
17. Ferro, D.A., et al., Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment. Neurology, 2019. 92(14): p. e1558-e1566.
18. Aoki, Y., et al., Cerebroprotective action of a Na+/Ca2+ channel blocker NS-7. I. Effect on the cerebral infarction and edema at the acute stage of permanent middle cerebral artery occlusion in rats. Brain Res, 2001. 890(1): p. 162-9.
19. Guo, Y., et al., Cerebral hemodynamic changes assessment by transcranial doppler ultrasound in patients with acute cerebral infarction before and after treatment with butylphthalide. Pak J Pharm Sci, 2022. 35(2(Special)): p. 613-618.
20. Zhou, X., et al., Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction. Appl Bionics Biomech, 2022. 2022: p. 9215685.
21. Chen, J., et al., Butylphthalide alleviates sleep deprivation-induced cognitive deficit by regulating Nrf2/HO-1 pathway. Sleep Med, 2022. 100: p. 427-433.
22. Zhou, Q., et al., Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis. CNS Neurosci Ther, 2022. 28(11): p. 1706-1717.
23. Li, K., et al., Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke. J Healthc Eng, 2022. 2022: p. 1509407.
24. Takeda, H., et al., Microglial metabolic disturbances and neuroinflammation in cerebral infarction. J Pharmacol Sci, 2021. 145(1): p. 130-139.
25. Zhang, W.T., J.Y. Niu, and C. He, Associations of OSAHS complicated by cerebral infarction with intestinal flora, inflammatory factors, homocysteine and adiponectin expression. Eur Rev Med Pharmacol Sci, 2020. 24(24): p. 12993-12999.
26. Teng, L. and R. Meng, Long Non-Coding RNA MALAT1 Promotes Acute Cerebral Infarction Through miRNAs-Mediated hs-CRP Regulation. J Mol Neurosci, 2019. 69(3): p. 494-504.
27. Li, M., et al., Clinical efficacy of aspirin combined with clopidogrel in treating cerebral infarction and its effect on serum hs-CRP, sICAM-1 and TNF-α. Exp Ther Med, 2020. 19(2): p. 939-944.
28. Ristagno, G., et al., Pentraxin 3 in Cardiovascular Disease. Front Immunol, 2019. 10: p. 823.
29. Bai, M., et al., Effects of butylphthalide on oxidative stress and inflammatory response in rats with myocardial infarction through Akt/Nrf2 signaling pathway. Eur Rev Med Pharmacol Sci, 2019. 23(21): p. 9642-9650.
30. Dong, Q., M. Wu, and W. Hu, Efficacy and association of hyperbaric oxygen therapy combined with butylphthalide and oxiracetam with serum levels of inflammatory markers in vascular cognitive impairment after acute ischemic stroke. Pak J Med Sci, 2023. 39(3): p. 829-834.
Published
2025/04/25
Issue
Vol. 44 No. 7 (2025): Journal of Medical Biochemistry
Section
Original paper

Copyright (c) 2025 Pin Meng, Jianyu Zhang, Jiaojiao Li, Niu Ji, Xinyu Zhou, Bingchao Xu

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.